La prise en charge du diabète de type 2 à l’ère des capteurs glycémiques
(2025) Louvain médical — Vol. 144, n° 3, p. 21-24 (2025)
Files
2025_Hermans_LM_21-24.pdf
Open Access - Adobe PDF
- 1.53 MB
Details
- Authors
- Abstract
- (en) [Management of type 2 diabetes in the era of blood glucose sensors] Blood glucose sensors for continuous interstitial glucose monitoring are reimbursed in Belgium for certain categories of type 2 diabetics treated with basal-prandial insulin regimens under the Diabetes Convention. They provide a better assessment of glycemic exposure, allowing finer tuning of insulin doses and adjustment of non-insulin glucose-lowering medications. As with type 1 diabetes, their use requires reevaluation of dietary practices and guided dietary counseling based on ambulatory measurements as a result of improved assessment of glycemic exposure, including postprandial excursions and nocturnal glucose.
- Affiliations
Citations
Hermans, M. (2025). La prise en charge du diabète de type 2 à l’ère des capteurs glycémiques. Louvain médical, 144(3), 21-24. https://hdl.handle.net/2078.5/244583 (Original work published 2025)